Furthermore, our current findings suggest that CDK6 may through regulating the cell cycle of tumor cells, in addition to modulating immune checkpoint expression and immune cell infiltration in tumors to exert its oncogenic effects. The gene discussed is CDK6; the disease is neoplasm.